购物车
- 全部删除
- 您的购物车当前为空
MDL-800,一种选择性SIRT6激活剂,通过将SIRT6的脱乙酰化活性提高多达22倍,有效促进了人类肝细胞癌(HCC)细胞中H3K9ac和H3K56ac水平的全面降低。SIRT6,作为一种肿瘤抑制因子,主要负责去乙酰化组蛋白H3 Nε-乙酰基赖氨酸9 (H3K9ac) 和56 (H3K56ac),在多种癌症中常发现其表达量低下。此外,MDL-800通过SIRT6驱动的细胞周期阻滞,抑制了HCC细胞的增殖,并在肿瘤异种移植模型中显示出了效果。
为众多的药物研发团队赋能,
让新药发现更简单!
MDL-800,一种选择性SIRT6激活剂,通过将SIRT6的脱乙酰化活性提高多达22倍,有效促进了人类肝细胞癌(HCC)细胞中H3K9ac和H3K56ac水平的全面降低。SIRT6,作为一种肿瘤抑制因子,主要负责去乙酰化组蛋白H3 Nε-乙酰基赖氨酸9 (H3K9ac) 和56 (H3K56ac),在多种癌症中常发现其表达量低下。此外,MDL-800通过SIRT6驱动的细胞周期阻滞,抑制了HCC细胞的增殖,并在肿瘤异种移植模型中显示出了效果。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 357 | 现货 | |
5 mg | ¥ 842 | 现货 | |
10 mg | ¥ 1,230 | 现货 | |
25 mg | ¥ 2,110 | 现货 | |
50 mg | ¥ 3,160 | 现货 | |
100 mg | ¥ 4,630 | 现货 | |
500 mg | ¥ 9,890 | 5日内发货 |
产品描述 | SIRT6, responsible for deacetylation of histone H3 Nε-acetyl-lysines 9 (H3K9ac) and 56 (H3K56ac), is a tumor suppressor which has frequently been found to have low expression in various cancers. MDL-800 is a selective SIRT6 activator. It increased the deacetylase activity of SIRT6 by up to 22-fold and led to a global decrease in H3K9ac and H3K56ac levels in human hepatocellular carcinoma (HCC) cells. Also, it inhibited the proliferation of HCC cells via SIRT6-driven cell-cycle arrest and was effective in a tumor xenograft model. |
别名 | MDL800, MDL 800 |
分子量 | 626.3 |
分子式 | C21H16BrCl2FN2O6S2 |
CAS No. | 2275619-53-7 |
Smiles | COC(=O)c1cc(NS(=O)(=O)c2cc(Cl)cc(Cl)c2)ccc1S(=O)(=O)Nc1cc(Br)c(F)cc1C |
密度 | 1.710 g/cm3 (Predicted) |
存储 | Shipping with blue ice. | ||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 45 mg/mL (71.85 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||
DMSO
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容